Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

benzoic acid compound

NULL

benzoic acid compound (NULL) is an FDA-listed pharmaceutical active ingredient.

TGA: approved
Patents linked 14
Pipeline programs 0
News articles 1
Drug details — benzoic acid compound
Class
—
Route
—
Patents
14
Programs
0
Data quality
0.78
← All drugs Related patents Drug news hub Event calendar

Quick answer

benzoic acid compound (NULL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN benzoic acid compound
Brand NULL

Approval history

Authority Status Date
TGA approved —

Recent coverage

View all news
Axsome FDA Approval for Alzheimer's Agitation Drug
Critical impact Newsagitation associated with Alzheimer's diseaseMay 3, 2026

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

Axsome Therapeutics has received FDA approval for a new treatment for agitation associated with Alzheimer's disease. This landmark decision addresses a critical unmet need and marks a significant step forward for the company and Alzheimer's patient care.

Dr. Priya Nandakumar

Related patents

Browse patents

  1. US 10071081

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    Expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9861617

    Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their use

    Expires Mon Jan 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9611230

    1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9205088

    Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

    Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8975287

    Methods for using 1,2,4-Oxadiazole benzoic acid compounds

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8796322

    Methods for using 1,2,4-oxadiazole benzoic acid compounds

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8691511

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays

    Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8334313

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8129540

    Methods for the synthesis of 1,2,4-oxadiazole benzoic acid compounds

    Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8101641

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7902241

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7772259

    1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7405233

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 6992096

    1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is benzoic acid compound?

benzoic acid compound (NULL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for benzoic acid compound?

NULL is a marketed brand name for benzoic acid compound. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.